Elliott, W., Jr.; Guda, M.R.; Asuthkar, S.; Teluguakula, N.; Prasad, D.V.R.; Tsung, A.J.; Velpula, K.K.
PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis. Biomedicines 2021, 9, 1867.
https://doi.org/10.3390/biomedicines9121867
AMA Style
Elliott W Jr., Guda MR, Asuthkar S, Teluguakula N, Prasad DVR, Tsung AJ, Velpula KK.
PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis. Biomedicines. 2021; 9(12):1867.
https://doi.org/10.3390/biomedicines9121867
Chicago/Turabian Style
Elliott, Willie, Jr., Maheedhara R. Guda, Swapna Asuthkar, Narasaraju Teluguakula, Durbaka V. R. Prasad, Andrew J. Tsung, and Kiran K. Velpula.
2021. "PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis" Biomedicines 9, no. 12: 1867.
https://doi.org/10.3390/biomedicines9121867
APA Style
Elliott, W., Jr., Guda, M. R., Asuthkar, S., Teluguakula, N., Prasad, D. V. R., Tsung, A. J., & Velpula, K. K.
(2021). PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis. Biomedicines, 9(12), 1867.
https://doi.org/10.3390/biomedicines9121867